On September 27-29, 2022 in Boston, MA, Dr. Dan Benjamin will be speaking at the 6th annual Complement-based Drug Development Summit, www.complement-therapeutics.com.

The title of the talk is:Targeted Delivery Platform of sC3, a Complement Depleting Protein, Using Viral Delivery, Conjugate Guidance, & Localized Application Modalities 


• Discover how specific cell types in the retina and kidney can be targeted to express sC3 

• Conjugate guidance and tissue specific local delivery are being developed to increase efficacy and decrease off target effects 

• Taken together, these technologies allow Cascade to optimize treatment based on the therapeutic target

Please contact Dr. Benjamin on this website or at: daniel.benjamin@cascadebiotechnology.com